神经分泌生物科学公司第二季度业绩表现强劲。调整后每股收益达2.85美元,而市场普遍预期仅为1.34美元,这一结果显著超出分析师的预估。
在第二季度,该公司公布的每股收益为1.39美元。(完)
神经分泌生物科学公司第二季度业绩表现强劲。调整后每股收益达2.85美元,而市场普遍预期仅为1.34美元,这一结果显著超出分析师的预估。
在第二季度,该公司公布的每股收益为1.39美元。(完)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.